Search Results

There are 14409 results for: content related to: Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats

  1. A comparison of the effect of nanotube chirality and electronic properties on the π–π interaction of single-wall carbon nanotubes with pyrazinamide antitubercular drug

    International Journal of Quantum Chemistry

    Volume 113, Issue 9, 5 May 2013, Pages: 1272–1284, Nabanita Saikia and Ramesh C. Deka

    Version of Record online : 16 JUL 2012, DOI: 10.1002/qua.24275

  2. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway

    Journal of Applied Toxicology

    Volume 36, Issue 12, December 2016, Pages: 1579–1590, Yun Zhang, Hongli Guo, Hozeifa M. Hassan, Ping-ping Ding, Yijing Su, Yuming Song, Tao Wang, Lixin Sun, Luyong Zhang and Zhenzhou Jiang

    Version of Record online : 12 APR 2016, DOI: 10.1002/jat.3319

  3. You have free access to this content
    Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation

    Liver Transplantation

    Volume 16, Issue 10, October 2010, Pages: 1136–1146, Philippe Ichai, Faouzi Saliba, Fadi Antoun, Daniel Azoulay, Mylène Sebagh, Teresa Maria Antonini, Lélia Escaut, Delvart Valérie, Denis Castaing and Didier Samuel

    Version of Record online : 30 JUN 2010, DOI: 10.1002/lt.22125

  4. Coencapsulation of Hydrophobic and Hydrophilic Antituberculosis Drugs in Synergistic Brij 96 Microemulsions: A Biophysical Characterization

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 7, July 2015, Pages: 2203–2212, Gurpreet Kaur, S.K. Mehta, Sandeep Kumar, Gaurav Bhanjana and Neeraj Dilbaghi

    Version of Record online : 7 MAY 2015, DOI: 10.1002/jps.24469

  5. Entrapment of multiple anti-Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 4, April 2010, Pages: 1896–1911, S.K. Mehta, Gurpreet Kaur and K.K. Bhasin

    Version of Record online : 5 NOV 2009, DOI: 10.1002/jps.21971

  6. You have free access to this content
    Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide

    Molecular Microbiology

    Volume 95, Issue 5, March 2015, Pages: 791–803, Juanjuan Yang, Yindi Liu, Jing Bi, Qixu Cai, Xinli Liao, Wenqian Li, Chenyun Guo, Qian Zhang, Tianwei Lin, Yufen Zhao, Honghai Wang, Jun Liu, Xuelian Zhang and Donghai Lin

    Version of Record online : 16 JAN 2015, DOI: 10.1111/mmi.12892

  7. Studies of the Binding of Modest Modulators of the Human Enzyme, Sirtuin 6, by STD NMR

    ChemBioChem

    Volume 18, Issue 10, May 18, 2017, Pages: 931–940, Beatriz E. Bolívar and Prof. John T. Welch

    Version of Record online : 18 APR 2017, DOI: 10.1002/cbic.201600655

  8. Analogs of the Antituberculous Agent Pyrazinamide Are Competitive Inhibitors of NADPH Binding to M. tuberculosis Fatty Acid Synthase I

    Chemistry & Biodiversity

    Volume 9, Issue 11, November 2012, Pages: 2582–2596, Halimah Sayahi, Kaitlin M. Pugliese, Oren Zimhony, William R. Jacobs Jr., Alexander Shekhtman and John T. Welch

    Version of Record online : 19 NOV 2012, DOI: 10.1002/cbdv.201200291

  9. Synthesis, solution properties and scale-inhibiting behaviour of a diallylammonium/sulfur dioxide cyclocopolymer bearing phospho- and sulfopropyl pendents

    Polymer International

    Volume 63, Issue 9, September 2014, Pages: 1682–1690, Shaikh A Ali and Shamsuddeen A Haladu

    Version of Record online : 19 FEB 2014, DOI: 10.1002/pi.4691

  10. You have full text access to this OnlineOpen article
    Uricosuric targets of tranilast

    Pharmacology Research & Perspectives

    Volume 5, Issue 2, April 2017, Asim K. Mandal, Adriana Mercado, Andria Foster, Kambiz Zandi-Nejad and David B. Mount

    Version of Record online : 6 FEB 2017, DOI: 10.1002/prp2.291

  11. Population pharmacokinetics of pyrazinamide in elephants

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 28, Issue 5, October 2005, Pages: 403–409, M. ZHU, J. N. MASLOW, S. K. MIKOTA, R. ISAZA, F. DUNKER, H. RIDDLE and C. A. PELOQUIN

    Version of Record online : 5 OCT 2005, DOI: 10.1111/j.1365-2885.2005.00670.x

  12. Cyclopolymerization protocol for the synthesis of a poly(zwitterion-alt-sulfur dioxide) to investigate the polyzwitterion-to-poly(anion-zwitterion) transition

    Journal of Applied Polymer Science

    Volume 129, Issue 3, 5 August 2013, Pages: 1394–1404, Shaikh A. Ali and Shamsuddeen A. Haladu

    Version of Record online : 10 DEC 2012, DOI: 10.1002/app.38835

  13. A pH-responsive cyclopolymer having phospho- and sulfopropyl pendents in the same repeating unit: Synthesis, characterization, and its application as an antiscalant

    Journal of Polymer Science Part A: Polymer Chemistry

    Volume 51, Issue 23, 1 December 2013, Pages: 5130–5142, Shamsuddeen A. Haladu and Shaikh A. Ali

    Version of Record online : 7 OCT 2013, DOI: 10.1002/pola.26945

  14. You have free access to this content
    Computational study of the putative active form of protein Z (PZa): Sequence design and structural modeling

    Protein Science

    Volume 17, Issue 8, August 2008, Pages: 1354–1361, Vasu Chandrasekaran, Chang Jun Lee, Robert E. Duke, Lalith Perera and Lee G. Pedersen

    Version of Record online : 2 JAN 2009, DOI: 10.1110/ps.034801.108

  15. Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: A toxicity profile study

    Hepatology Research

    Volume 37, Issue 10, October 2007, Pages: 845–853, Sheikh Abdullah Tasduq, Peerzada Kaiser, Subhash Chander Sharma and Rakesh Kamal Johri

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1872-034X.2007.00129.x

  16. A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis

    Chemical Biology & Drug Design

    Volume 87, Issue 4, April 2016, Pages: 537–550, Ameeruddin Nusrath Unissa, Luke Elizabeth Hanna and Soumya Swaminathan

    Version of Record online : 17 JAN 2016, DOI: 10.1111/cbdd.12684

  17. You have free access to this content
    Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses

    British Journal of Clinical Pharmacology

    Volume 65, Issue 3, March 2008, Pages: 423–427, Pooja Gupta, Vandana Roy, Gulshan Rai Sethi and Tarun Kumar Mishra

    Version of Record online : 18 DEC 2007, DOI: 10.1111/j.1365-2125.2007.03069.x

  18. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry

    APMIS

    Volume 124, Issue 11, November 2016, Pages: 1004–1015, Julie B. Prahl, Marika Lundqvist, Justyna M. C. Bahl, Isik S. Johansen, Åse B. Andersen, Niels Frimodt-Møller and Arieh S. Cohen

    Version of Record online : 22 AUG 2016, DOI: 10.1111/apm.12590

  19. A Semi-active piezoelectric friction damper

    Earthquake Engineering & Structural Dynamics

    Volume 44, Issue 3, March 2015, Pages: 333–354, J. Pardo-Varela and J. C. de la Llera

    Version of Record online : 14 OCT 2014, DOI: 10.1002/eqe.2469

  20. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex

    APMIS

    Volume 101, Issue 1-6, January 1993, Pages: 154–159, KURT FUURSTED

    Version of Record online : 15 AUG 2009, DOI: 10.1111/j.1699-0463.1993.tb00095.x